Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × binimetinib × Sarcoma × Clear all

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 17 CNS 9 Gastrointestinal 6 Thoracic 5 Other hematologic neoplasm 4 Plasma cell 2 Gynecologic 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Lymphoid 1 Head & Neck 1

Conditions

Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Cyclophosphamide 87 Doxorubicin 80 Radiotherapy 76 Temozolomide 63 Filgrastim 48 Ifosfamide 47 Bevacizumab 46 Etoposide 42 Imatinib Mesylate 39 Gemcitabine 37 Vincristine 35 pembrolizumab 30 pazopanib 28 Irinotecan 28 fludarabine phosphate 25 Peripheral Blood Stem Cell Transplantation 25 Methotrexate 25 Nivolumab 24 Carboplatin 24 Melphalan 23 Trabectedin 22 Magnetic Resonance Spectroscopy 22 Docetaxel 22 Cisplatin 22 Busulfan 22 Paclitaxel 21 Sirolimus 19 Rituximab 19 Mycophenolic Acid 18 Antilymphocyte Serum 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡